Tirzepatide – 80mg (10 vials)

Product Overview

Tirzepatide is a synthetic peptide-based medicinal compound that acts on GIP and GLP-1 receptors. These receptors are involved in glucose regulation and metabolic signaling, making tirzepatide relevant to scientific study of incretin-related pathways.

Scientific Background

Tirzepatide has been studied for its dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its pharmacological properties are relevant to research and clinical investigation involving metabolic regulation.

Product Specifications

• Product Name: Tirzepatide
• Listed Strength: 80mg
• Package Format: 10 vials
• Compound Category: Peptide-based medicinal compound
• Research Focus: GIP and GLP-1 receptor signaling

Product Information and Verification

Confirm the manufacturer’s label, strength per vial, total package quantity, storage instructions, and available quality documentation before publishing the product listing. The listed 80mg strength should be clarified as either the amount per vial or the total amount across all 10 vials.

Regulatory Disclaimer

Tirzepatide is a regulated medicinal compound. This listing is informational and does not constitute medical advice. Do not imply that the product is approved for research-only sale or human use without verifying the applicable regulatory requirements and authorized labeling in the intended market.